The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer.
Andrea PaganiDominik DuscherSebastian GeisSilvan KleinLeonard KnoedlerAdriana C PanayiDmytro OliinykOliver FelthausLukas PrantlPublished in: Cells (2024)
The possibility of impacting triple-negative breast cancer cells with engineered Adipose-Derived Stem Cell Exosomes is real. The opportunity to translate our current in vitro analyses into a future in vivo scenario is even more challenging.